Clarivate to Sell Life-sciences, Healthcare Segment to Altaris for $600 Million

Dow Jones

Jul 06

Clarivate inked a deal to sell its life-sciences and healthcare segment to investment firm Altaris for $600 million.

Clarivate on Monday said the move will allow the London provider of global information, analytics and workflow solutions to focus on AI-driven intelligence for its academia and government and intellectual-property segments.

Clarivate said it will receive $500 million in cash at closing, along with $25 million in cash deferred to the completion of a transition-services agreement and a $75 million seller note, adding that it plans to use the cash proceeds to pare its debt load and bolster its balance sheet.

The company said it expects to complete the sale by the end of the year, and that it expects to book a non-cash goodwill impairment of $225 million to $250 million on the life-sciences and healthcare segment.

Altaris, a New York firm that focuses exclusively on the healthcare industry and manages more than $9 billion of equity capital, last month agreed to buy drug-development company Simulations Plus for around $375 million.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

July 06, 2026 06:28 ET (10:28 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2649623661"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2649623661\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2649623661?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-06 18:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2649623661","market":"hk","top_or_hot":-1,"title":"Clarivate to Sell Life-sciences, Healthcare Segment to Altaris for $600 Million","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Clarivate inked a deal to sell its life-sciences and healthcare segment to investment firm Altaris for $600 million. \n</p>\n<p>\n  Clarivate on Monday said the move will allow the London provider of global information, analytics and workflow solutions to focus on AI-driven intelligence for its academia and government and intellectual-property segments. \n</p>\n<p>\n  Clarivate said it will receive $500 million in cash at closing, along with $25 million in cash deferred to the completion of a transition-services agreement and a $75 million seller note, adding that it plans to use the cash proceeds to pare its debt load and bolster its balance sheet. \n</p>\n<p>\n  The company said it expects to complete the sale by the end of the year, and that it expects to book a non-cash goodwill impairment of $225 million to $250 million on the life-sciences and healthcare segment. \n</p>\n<p>\n  Altaris, a New York firm that focuses exclusively on the healthcare industry and manages more than $9 billion of equity capital, last month agreed to buy drug-development company <a href=\"https://laohu8.com/S/SLP\">Simulations Plus</a> for around $375 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 06, 2026 06:28 ET (10:28 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clarivate to Sell Life-sciences, Healthcare Segment to Altaris for $600 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClarivate to Sell Life-sciences, Healthcare Segment to Altaris for $600 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-06 18:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Clarivate inked a deal to sell its life-sciences and healthcare segment to investment firm Altaris for $600 million. \n</p>\n<p>\n  Clarivate on Monday said the move will allow the London provider of global information, analytics and workflow solutions to focus on AI-driven intelligence for its academia and government and intellectual-property segments. \n</p>\n<p>\n  Clarivate said it will receive $500 million in cash at closing, along with $25 million in cash deferred to the completion of a transition-services agreement and a $75 million seller note, adding that it plans to use the cash proceeds to pare its debt load and bolster its balance sheet. \n</p>\n<p>\n  The company said it expects to complete the sale by the end of the year, and that it expects to book a non-cash goodwill impairment of $225 million to $250 million on the life-sciences and healthcare segment. \n</p>\n<p>\n  Altaris, a New York firm that focuses exclusively on the healthcare industry and manages more than $9 billion of equity capital, last month agreed to buy drug-development company <a href=\"https://laohu8.com/S/SLP\">Simulations Plus</a> for around $375 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 06, 2026 06:28 ET (10:28 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4137","symbol_name":"综合支持服务","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2649623661","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2649623661","pubTimestamp":1783333680,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Clarivate inked a deal to sell its life-sciences and healthcare segment to investment firm Altaris for $600 million.Clarivate on Monday said the move will allow the London provider of global information, analytics and workflow solutions to focus on AI-driven intelligence for its academia and government and intellectual-property segments.Clarivate said it will receive $500 million in cash at closing, along with $25 million in cash deferred to the completion of a transition-services agreement and a $75 million seller note, adding that it plans to use the cash proceeds to pare its debt load and bolster its balance sheet.The company said it expects to complete the sale by the end of the year, and that it expects to book a non-cash goodwill impairment of $225 million to $250 million on the life-sciences and healthcare segment.Altaris, a New York firm that focuses exclusively on the healthcare industry and manages more than $9 billion of equity capital, last month agreed to buy drug-developm","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4137":"综合支持服务","HCSG":"Healthcare Svcs Group Inc","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4561":"索罗斯持仓","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4123":"调查和咨询服务","BK4581":"高盛持仓","XBI":"SPDR S&P Biotech ETF","XLV":"健康照护类股ETF-SPDR","CLVT":"Clarivate Plc","LABU":"三倍做多标普生物-Direxion"},"translate_title":"科睿唯安将以6亿美元将生命科学和医疗保健部门出售给Altaris","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLVT":0.9,"HCSG":1.5,"XBI":0.6,"LABU":0.6,"XLV":1.5},"content_text":"Clarivate inked a deal to sell its life-sciences and healthcare segment to investment firm Altaris for $600 million. \n\n\n  Clarivate on Monday said the move will allow the London provider of global information, analytics and workflow solutions to focus on AI-driven intelligence for its academia and government and intellectual-property segments. \n\n\n  Clarivate said it will receive $500 million in cash at closing, along with $25 million in cash deferred to the completion of a transition-services agreement and a $75 million seller note, adding that it plans to use the cash proceeds to pare its debt load and bolster its balance sheet. \n\n\n  The company said it expects to complete the sale by the end of the year, and that it expects to book a non-cash goodwill impairment of $225 million to $250 million on the life-sciences and healthcare segment. \n\n\n  Altaris, a New York firm that focuses exclusively on the healthcare industry and manages more than $9 billion of equity capital, last month agreed to buy drug-development company Simulations Plus for around $375 million. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 06, 2026 06:28 ET (10:28 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}